| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 8 | |
| #2 | Australia | 2 | |
| #3 | Brazil | 2 | |
| #4 | Canada | 2 | |
| #5 | China | 2 | |
| #6 | EPO (European Patent Office) | 2 | |
| #7 | Taiwan | 2 | |
| #8 | United States | 2 | |
| #9 | Republic of Korea | 1 | |
| #10 | Mexico | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Chen Lieping | 21 |
| #2 | Luo Liqun | 19 |
| #3 | Wen Zhenguo | 5 |
| #4 | Liu Qianyong | 5 |
| #5 | Liqun Luo | 3 |
| #6 | Lieping Chen | 3 |
| #7 | Luo Li-Qun | 2 |
| #8 | Yang Jianguo | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020151572A1 | Anti-pd-l1 diabodies and the use thereof | |
| WO2020015722A1 | Anti-pd-1 antibodies, dosages and uses thereof | |
| CA3102230A1 | Compositions and uses thereof for treating disease or condition | |
| WO2020019232A1 | Compositions and methods for imaging | |
| WO2019227490A1 | Compositions and methods for imaging | |
| TW202003558A | Anti-PD-1 antibodies and uses thereof | |
| WO2018133837A1 | Anti-pd-1 antibodies and uses thereof |